Pathway Explorer

Select the following drugs to display the signaling pathways associated with head and neck cancer drug resistance.         

Cisplatin
Cisplatin
5-fluorouracil
5-fluorouracil
Cetuximab
Cetuximab
Docetaxel
Docetaxel
Paclitaxel
Paclitaxel
Vincristine
Vincristine
Bleomycin
Bleomycin
Pingyangmycin
Pingyangmycin
Dasatinib
Dasatinib
Gemcitabine
Gemcitabine
Apatinib
Apatinib
Trametinib
Trametinib